TCL Archive After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business January 19, 1996
TCL Archive FDA Oncology Division Invites Advocates To Play Early Role In Cancer Drug Review. March 23, 2001
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
